Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

HV Bancorp Q2 EPS $0.31 Down From $0.63 YoY

HV Bancorp (NASDAQ:HVBC) reported quarterly earnings of $0.31 per share. This is a 50.79 percent decrease over earnings of $0.63 per share from the same period last year.
byBenzinga Newsdesk
August 5, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

HV Bancorp (NASDAQ:HVBC) reported quarterly earnings of $0.31 per share. This is a 50.79 percent decrease over earnings of $0.63 per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

AffaMed Therapeutics Announced Top-Line Results From Real-World Study In China Evaluating The Safety And Efficacy Of DEXTENZA In Patients After Cataract Surgery; NOTE: AffaMed Therapeutics Has A Licensing Agreement With Ocular Therapeutix, Inc.

By Benzinga Newsdesk
October 31, 9:07 AM
AffaMed Therapeutics ("AffaMed"), a global biotechnology company dedicated to developing and commercializing transformative pharmaceutical, digital and surgical products that address critical unmet medical needs in

OCUL